Journals / Annals of Medical Research / 2020 / Cilt: 27 - Sayı: 10

Perioperative or intraoperative blood transfusion increases the risk of postoperative pancreatic fistula following pancreaticoduodenectomy

Pages
2585–2591
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We also found that reduce the POPF risk, it is important to avoid blood transfusion whenever possible.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Postoperative pancreatic fistula (POPF) is one of the most common causes of morbidity following pancreaticoduodenectomy (PD).
📊
Key Findings & Data:Material and Methods: In this study, we included patients who had undergone PD from January 2010 to April 2020.
💡
Conclusion & Impact:We also found that reduce the POPF risk, it is important to avoid blood transfusion whenever possible.
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Postoperative pancreatic fistula (POPF) is one of the most common causes of morbidity following pancreaticoduodenectomy (PD). The optimum way of reducing the prevalence of POPF is to prevent its development. In this study, we attempted to identify the potential perioperative risk factors of POPF and suggestions were made for its. Material and Methods: In this study, we included patients who had undergone PD from January 2010 to April 2020. POPF was defined as per the International Study Group on Pancreatic Fistula. The patients were followed up for 30 days for POPF.Results: Fifty-two (52) patients whose medical records were available were enrolled. POPF developed in 19 patients (36.5%). Grade-A POPF developed in six patients (11.5%), Grade-B POPF in eight patients (15.4%), and Grade-C POPF in five patients (9.6%). Percutaneous drainage was performed in a patient with Grade-B POPF, and reoperation was performed for five patients with Grade-C POPF. In univariate analysis, female sex (p=0.03), perioperative blood transfusion (p=0.03), and the number of harvested lymph nodes ≥12 (p=0.008) were related to POPF. In logistic regression analysis, the number of harvested lymph nodes ≥12 (p=0.005) and female sex (p=0.03) were independent risk factors of POPF. Although perioperative blood transfusion increased the POPF risk, the effect was not statistically significant (p=0.10).Conclusion: POPF was observed to be the most important cause of morbidity following PD in our study. We also found that reduce the POPF risk, it is important to avoid blood transfusion whenever possible.

🔖

Cite This Article

TÜRKYILMAZ, S., GÜNER, A., ULUŞAHİN, M., ÇEKİÇ, A. B., AKTAŞ, A., ATEŞ, M., REİS, M. E. (2022). Perioperative or intraoperative blood transfusion increases the risk of postoperative pancreatic fistula following pancreaticoduodenectomy. Annals of Medical Research, Cilt: 27 - Sayı: 10, 2585–2591. https://ajindex.com/articles/446293

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Qin H, Luo L, Zhu Z, et al. Pancreaticogastrostomy has advantages over pancreaticojejunostomy on pancreatic fistula after pancreaticoduodenectomy. A meta-analysis of randomized controlled trials. Int J Surg 2016;36:18-24
  2. Ramacciato G, Mercantini P, Petrucciani N, et al. Risk factors of pancreatic fistula after pancreaticoduodenectomy: a collective review. Am Surg 2011;77:257-69
  3. Chen JS, Liu G, Li TR, et al. Pancreatic fistula after pancreaticoduodenectomy: Risk factors and preventive strategies. J Cancer Res Ther 2019;15:857- 63
  4. Ke ZX, Xiong JX, Hu J, et al. Risk Factors and Management of Postoperative Pancreatic Fistula Following Pancreaticoduodenectomy: Single-center Experience. Curr Med Sci 2019;39:1009-18
  5. Bassi C, Falconi M, Molinari E, et al. Reconstruction by pancreaticojejunostomy versus pancreaticogastrostomy following pancreatectomy: results of a comparative study. Ann Surg 2005;242:767-73
  6. Pan SB, Geng W, Zhou DC, et al. One-layer versus two-layer duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy: study protocol for a randomized controlled trial. Trials 2016;17:407
  7. Fujii T, Sugimoto H, Yamada S, et al. Modified Blumgart anastomosis for pancreaticojejunostomy: technical improvement in matched historical control study. J Gastrointest Surg 2014;18:1108-15
  8. Winter JM, Cameron JL, Campbell KA, et al. Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg 2006;10:1280-90
  9. Shan YS, Sy ED, Lin PW. Role of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenectomy in highrisk patients and elimination of surgeon-related factors: prospective, randomized, controlled trial. World J Surg 2003;27:709-14
  10. Hu BY, Wan T, Zhang WZ, et al. Risk factors for postoperative pancreatic fistula: Analysis of 539 successive cases of pancreaticoduodenectomy. World J Gastroenterol 2016;22:7797-805
  11. Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery 2017;161:584-91
  12. Xiong JJ, Tan CL, Szatmary P, et al. Metaanalysis of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Br J Surg 2014;101:1196–208
  13. Allen PJ, Gönen M, Brennan MF, et al: Pasireotide for postoperative pancreatic fistula. N E